Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 5. Oseltamivir carboxylate

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 8, 2016, Pages 5085-5087

  Galindo Bedor, Danilo Cesar ^a,d   Marchand, Sandrine ^a,b,c   Lamarche, Isabelle ^a,b   Laroche, Julian ^a,b   Pereira De Santana, Davi ^d   Couet, William ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

4 ACETAMIDO 5 AMINO 3 (1 ETHYLPROPOXY) 1 CYCLOHEXENE 1 CARBOXYLIC ACID; ANTIINFECTIVE AGENT; OSELTAMIVIR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG HALF LIFE; EPITHELIAL LINING FLUID; LUNG LAVAGE; MALE; NEBULIZATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; RAT; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT;

ADMINISTRATION, INHALATION; ADMINISTRATION, INTRAVENOUS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BRONCHOALVEOLAR LAVAGE; MALE; OSELTAMIVIR; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84979533899     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00909-16     Document Type: Article

References (12)

1. Gontijo AV, Brillault J, Gregoire N, Lamarche I, Gobin P, Couet W, Marchand S. 2014. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin. Antimicrob Agents Chemother 58:3942-3949. http://dx.doi.org/10.1128/AAC.02818-14.
2. Gontijo AV, Gregoire N, Lamarche I, Gobin P, Couet W, Marchand S. 2014. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. Colistin. Antimicrob Agents Chemother 58:3950-3956. http://dx.doi.org/10.1128/AAC.02819-14.
3. Marchand S, Gregoire N, Brillault J, Lamarche I, Gobin P, Couet W. 2015. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 3. Tobramycin. Antimicrob Agents Chemother 59:6646-6647. http://dx.doi.org/10.1128/AAC.01647-15.
4. Marchand S, Gregoire N, Brillault J, Lamarche I, Gobin P, Couet W. 2016. Biopharmaceutical characterization of nebulized antimicrobial agents in rats. 4. Aztreonam. Antimicrob Agents Chemother 60:3196-3198. http://dx.doi.org/10.1128/AAC.00165-16.
5. Bardsley-Elliot A, Noble S. 1999. Oseltamivir. Drugs 58:851-860. http://dx.doi.org/10.2165/00003495-199958050-00007.
6. He G, Massarella J, Ward P. 1999. Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet 37:471-484. http://dx.doi.org/10.2165/00003088-199937060-00003.
7. Gupta D, Varghese Gupta S, Dahan A, Tsume Y, Hilfinger J, Lee KD, Amidon GL. 2013. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue. Mol Pharm 10:512-522. http://dx.doi.org/10.1021/mp300564v.
8. Marchand S, Gobin P, Brillault J, Baptista S, Adier C, Olivier JC, Mimoz O, Couet W. 2010. Aerosol therapy with colistin methanesulfonate: a biopharmaceutical issue illustrated in rats. Antimicrob Agents Chemother 54:3702-3707. http://dx.doi.org/10.1128/AAC.00411-10.
9. Brillault J, De Castro WV, Harnois T, Kitzis A, Olivier JC, Couet W. 2009. P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model. Antimicrob Agents Chemother 53:1457-1462. http://dx.doi.org/10.1128/AAC.01253-08.
10. Brillault J, De Castro WV, Couet W. 2010. Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model. Antimicrob Agents Chemother 54:543-545. http://dx.doi.org/10.1128/AAC.00733-09.
11. Samson M, Pizzorno A, Abed Y, Boivin G. 2013. Influenza virus resistance to neuraminidase inhibitors. Antiviral Res 98:174-185. http://dx.doi.org/10.1016/j.antiviral.2013.03.014.
12. Hu ZY, Edginton AN, Laizure SC, Parker RB. 2014. Physiologically based pharmacokinetic modeling of impaired carboxylesterase-1 activity: effects on oseltamivir disposition. Clin Pharmacokinet 53:825-836. http://dx.doi.org/10.1007/s40262-014-0160-3.